speb/financial-data huggingface dataset:
ORMP income_statement (quarterly, 2025-03-31) — Total Unusual Items: -3062000.00
ORMP income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -3062000.00
ORMP cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: 3348000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Working Capital: 125984000.00
ORMP income_statement (quarterly, 2025-06-30) — +Operating Expense: 2489000.00
ORMP income_statement (quarterly, 2025-06-30) — +Total Revenue: 0.00
ORMP balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 715000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 325008000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 12313000.00
ORMP income_statement (quarterly, 2025-06-30) — Basic Average Shares: 41743486.00
ORMP income_statement (quarterly, 2025-06-30) — Basic EPS: 0.32
ORMP cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 74516000.00
ORMP cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -4000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 912000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Capital Stock: 491000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 15797000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 97940000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Cash Financial: 15797000.00
ORMP cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -371000.00
ORMP cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -54853000.00
ORMP cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -3535000.00
ORMP cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -3095000.00
ORMP cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: 0.00
ORMP cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 307000.00
ORMP cash_flow (quarterly, 2025-06-30) — Change In Payable: -3095000.00
ORMP cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -3095000.00
ORMP cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 149000.00
ORMP cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -2639000.00
ORMP cash_flow (quarterly, 2025-06-30) — Changes In Cash: -58759000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Common Stock: 491000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 154529000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Construction In Progress: 1951000.00
ORMP income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 0.00
ORMP balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 1100000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Current Assets: 99026000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 264000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 264000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 1236000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 1236000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 3693000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Defined Pension Benefit: 38000.00
ORMP cash_flow (quarterly, 2025-06-30) — Depreciation: 30000.00
ORMP cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 30000.00
ORMP cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 30000.00
ORMP income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 42609425.00
ORMP income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.31
ORMP income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 13288000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Dueto Related Parties Current: 34000.00
ORMP income_statement (quarterly, 2025-06-30) — EBIT: 13134000.00
ORMP income_statement (quarterly, 2025-06-30) — EBITDA: 13164000.00
ORMP cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 40000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Employee Benefits: 36000.00
ORMP cash_flow (quarterly, 2025-06-30) — End Cash Position: 15797000.00
ORMP cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -371000.00
ORMP cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -3539000.00
ORMP income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 1455000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Gross PPE: 3478000.00
ORMP income_statement (quarterly, 2025-06-30) — Gross Profit: 0.00
ORMP balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 344000.00
ORMP income_statement (quarterly, 2025-06-30) — Interest Expense: 0.00
ORMP income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 0.00
ORMP income_statement (quarterly, 2025-06-30) — Interest Income: 15366000.00
ORMP income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 15366000.00
ORMP cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 0.00
ORMP balance_sheet (quarterly, 2025-06-30) — Invested Capital: 154529000.00
ORMP cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -54853000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 12313000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 56611000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Investmentsin Associatesat Cost: 44298000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 648000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 648000.00
ORMP cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: 0.00
ORMP balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 44298000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Minority Interest: -946000.00
ORMP income_statement (quarterly, 2025-06-30) — Minority Interests: 28000.00
ORMP cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: 0.00
ORMP cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: -203000.00
ORMP income_statement (quarterly, 2025-06-30) — Net Income: 13288000.00
ORMP income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 13288000.00
ORMP income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 13260000.00
ORMP income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 13288000.00
ORMP income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 13288000.00
ORMP cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 13260000.00
ORMP income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 13260000.00
ORMP income_statement (quarterly, 2025-06-30) — Net Interest Income: 15366000.00
ORMP cash_flow (quarterly, 2025-06-30) — Net Investment Properties Purchase And Sale: -755000.00
ORMP cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -54800000.00
ORMP cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 0.00
ORMP cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 0.00
ORMP income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 15366000.00
ORMP cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 706000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Net PPE: 3478000.00
ORMP cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -4000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 154529000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 3724000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 3724000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Non Current Note Receivables: 2529000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 36000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Non Current Prepaid Assets: 2000.00
ORMP income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 13164000.00
ORMP income_statement (quarterly, 2025-06-30) — Normalized Income: 13288000.00
ORMP cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -3535000.00
ORMP cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -209000.00
ORMP income_statement (quarterly, 2025-06-30) — Operating Income: -2489000.00
ORMP income_statement (quarterly, 2025-06-30) — Operating Revenue: 0.00
ORMP balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 40845087.00
ORMP balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 1086000.00
ORMP income_statement (quarterly, 2025-06-30) — Other Gand A: 1455000.00
ORMP income_statement (quarterly, 2025-06-30) — Other Income Expense: 257000.00
ORMP income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 257000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Other Properties: 1527000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 82143000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Payables: 1093000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 2193000.00
ORMP cash_flow (quarterly, 2025-06-30) — Pension And Employee Benefit Expense: -6000.00
ORMP income_statement (quarterly, 2025-06-30) — Pretax Income: 13134000.00
ORMP cash_flow (quarterly, 2025-06-30) — Purchase Of Business: 0.00
ORMP cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -63571000.00
ORMP cash_flow (quarterly, 2025-06-30) — Purchase Of Investment Properties: -755000.00
ORMP cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -4000.00
ORMP income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 0.00
ORMP income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 30000.00
ORMP cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: 0.00
ORMP income_statement (quarterly, 2025-06-30) — Research And Development: 1034000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -170970000.00
ORMP cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 8771000.00
ORMP income_statement (quarterly, 2025-06-30) — Selling General And Administration: 1455000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Share Issued: 40845087.00
ORMP cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 800000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 154529000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 154529000.00
ORMP income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
ORMP income_statement (quarterly, 2025-06-30) — Tax Provision: -126000.00
ORMP income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
ORMP balance_sheet (quarterly, 2025-06-30) — Total Assets: 161684000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 154529000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Total Debt: 912000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 153583000.00
ORMP income_statement (quarterly, 2025-06-30) — Total Expenses: 2489000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 8101000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 62658000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 4408000.00
ORMP income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -2489000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 344000.00
ORMP cash_flow (quarterly, 2025-06-30) — Unrealized Gain Loss On Investment Securities: -14777000.00
ORMP balance_sheet (quarterly, 2025-06-30) — Working Capital: 95333000.00
ORMP income_statement (quarterly, 2025-09-30) — +Operating Expense: 2427000.00
ORMP income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
ORMP balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 560000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 325367000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 14934000.00
ORMP income_statement (quarterly, 2025-09-30) — Basic Average Shares: 41756301.00
ORMP income_statement (quarterly, 2025-09-30) — Basic EPS: 1.16
ORMP cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 15797000.00
ORMP cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -2128000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 860000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Capital Stock: 490000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 52179000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 134687000.00
ORMP cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -361000.00
ORMP cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 38364000.00
ORMP cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -1625000.00
ORMP cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 2673000.00
ORMP cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: 0.00
ORMP cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -463000.00
ORMP cash_flow (quarterly, 2025-09-30) — Change In Payable: 2673000.00
ORMP cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 2673000.00
ORMP cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -553000.00
ORMP cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 1657000.00
ORMP cash_flow (quarterly, 2025-09-30) — Changes In Cash: 36378000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Common Stock: 490000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 203282000.00
ORMP cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -361000.00
ORMP income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 0.00
ORMP balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 818000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Current Assets: 136117000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 271000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 271000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 986000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 986000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 6119000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Defined Pension Benefit: 40000.00
ORMP cash_flow (quarterly, 2025-09-30) — Depreciation: 31000.00
ORMP cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 31000.00
ORMP cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 31000.00
ORMP income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 42774504.00
ORMP income_statement (quarterly, 2025-09-30) — Diluted EPS: 1.13
ORMP income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 48395000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Dueto Related Parties Current: 1000.00
ORMP income_statement (quarterly, 2025-09-30) — EBIT: 59451000.00
ORMP income_statement (quarterly, 2025-09-30) — EBITDA: 59482000.00
ORMP cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 4000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Employee Benefits: 38000.00
ORMP cash_flow (quarterly, 2025-09-30) — End Cash Position: 52179000.00
ORMP cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -361000.00
ORMP cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -3753000.00
ORMP income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 1274000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Gross PPE: 1431000.00
ORMP income_statement (quarterly, 2025-09-30) — Gross Profit: 0.00
ORMP cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 0.00
ORMP balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 3483000.00
ORMP income_statement (quarterly, 2025-09-30) — Interest Expense: 0.00
ORMP income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 0.00
ORMP cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 0.00
ORMP balance_sheet (quarterly, 2025-09-30) — Invested Capital: 203282000.00
ORMP cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 38364000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Investment Properties: 2122000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 14934000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 79737000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Investmentsin Associatesat Cost: 64803000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 589000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 589000.00
ORMP cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: 0.00
ORMP balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 64803000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Minority Interest: -952000.00
ORMP income_statement (quarterly, 2025-09-30) — Minority Interests: 6000.00
ORMP cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 0.00
ORMP cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -361000.00
ORMP cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: 823000.00
ORMP income_statement (quarterly, 2025-09-30) — Net Income: 48395000.00
ORMP income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 48395000.00
ORMP income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 48389000.00
ORMP income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 48395000.00
ORMP income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 48395000.00
ORMP cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 48389000.00
ORMP income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 48389000.00
ORMP income_statement (quarterly, 2025-09-30) — Net Interest Income: 61470000.00
ORMP cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 35734000.00
ORMP cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 0.00
ORMP cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 0.00
ORMP income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 61470000.00
ORMP cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 2809000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Net PPE: 1431000.00
ORMP cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -2128000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 203282000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 11417000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 3496000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 7921000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Non Current Note Receivables: 1044000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Non Current Pension And Other Postretirement Benefit Plans: 38000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Non Current Prepaid Assets: 2000.00
ORMP income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 59482000.00
ORMP income_statement (quarterly, 2025-09-30) — Normalized Income: 48395000.00
ORMP cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -1625000.00
ORMP cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 821000.00
ORMP income_statement (quarterly, 2025-09-30) — Operating Income: -2427000.00
ORMP income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
ORMP balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 40838226.00
ORMP balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 1430000.00
ORMP income_statement (quarterly, 2025-09-30) — Other Gand A: 1274000.00
ORMP income_statement (quarterly, 2025-09-30) — Other Income Expense: 408000.00
ORMP income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 408000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Other Properties: 1431000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 82508000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Payables: 4044000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 4862000.00
ORMP cash_flow (quarterly, 2025-09-30) — Pension And Employee Benefit Expense: -2000.00
ORMP income_statement (quarterly, 2025-09-30) — Pretax Income: 59451000.00
ORMP cash_flow (quarterly, 2025-09-30) — Purchase Of Business: 0.00
ORMP cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -2246000.00
ORMP cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -2128000.00
ORMP income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 0.00
ORMP income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 31000.00
ORMP cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: 0.00
ORMP cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -361000.00
ORMP income_statement (quarterly, 2025-09-30) — Research And Development: 1153000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -122575000.00
ORMP cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 37980000.00
ORMP income_statement (quarterly, 2025-09-30) — Selling General And Administration: 1274000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Share Issued: 40838226.00
ORMP cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 719000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 203282000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 203282000.00
ORMP income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
ORMP income_statement (quarterly, 2025-09-30) — Tax Provision: 11062000.00
ORMP income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.19
ORMP balance_sheet (quarterly, 2025-09-30) — Total Assets: 220493000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 203282000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Total Debt: 860000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 202330000.00
ORMP income_statement (quarterly, 2025-09-30) — Total Expenses: 2427000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 18163000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 84376000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 12044000.00
ORMP income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -2427000.00
ORMP income_statement (quarterly, 2025-09-30) — Total Other Finance Cost: -61470000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 3483000.00
ORMP cash_flow (quarterly, 2025-09-30) — Unrealized Gain Loss On Investment Securities: -61163000.00
ORMP balance_sheet (quarterly, 2025-09-30) — Working Capital: 129998000.00
ORMP income_statement (annual, 2025-12-31) — +Operating Expense: 15101000.00
ORMP income_statement (quarterly, 2025-12-31) — +Operating Expense: 5672000.00
ORMP income_statement (annual, 2025-12-31) — +Total Revenue: 2000000.00
ORMP income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
ORMP balance_sheet (annual, 2025-12-31) — Accounts Payable: 443000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 443000.00
ORMP balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 322708000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 322708000.00
ORMP balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 13743000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 13743000.00
ORMP income_statement (annual, 2025-12-31) — Basic Average Shares: 41402997.00
ORMP income_statement (annual, 2025-12-31) — Basic EPS: 1.53
ORMP cash_flow (annual, 2025-12-31) — Beginning Cash Position: 54420000.00
ORMP cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 52179000.00
ORMP cash_flow (annual, 2025-12-31) — Capital Expenditure: -1933000.00
ORMP balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 825000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 825000.00
ORMP balance_sheet (annual, 2025-12-31) — Capital Stock: 472000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Capital Stock: 472000.00
ORMP balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 45947000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 45947000.00
ORMP balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 125894000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 125894000.00
ORMP cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -4741000.00
ORMP cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -4009000.00
ORMP cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 5443000.00
ORMP cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -1684000.00
ORMP cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -9145000.00
ORMP cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -466000.00
ORMP cash_flow (annual, 2025-12-31) — Change In Account Payable: 1130000.00
ORMP cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 1737000.00
ORMP cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -60000.00
ORMP cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 0.00
ORMP cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -1979000.00
ORMP cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 173000.00
ORMP cash_flow (annual, 2025-12-31) — Change In Payable: 1130000.00
ORMP cash_flow (quarterly, 2025-12-31) — Change In Payable: 1737000.00
ORMP cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 1130000.00
ORMP cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 1737000.00
ORMP cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -998000.00
ORMP cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -1261000.00
ORMP cash_flow (annual, 2025-12-31) — Change In Working Capital: -1907000.00
ORMP cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 649000.00
ORMP cash_flow (annual, 2025-12-31) — Changes In Cash: -8443000.00
ORMP cash_flow (quarterly, 2025-12-31) — Changes In Cash: -6159000.00
ORMP balance_sheet (annual, 2025-12-31) — Common Stock: 472000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Common Stock: 472000.00
ORMP balance_sheet (annual, 2025-12-31) — Common Stock Equity: 199744000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 199744000.00
ORMP cash_flow (annual, 2025-12-31) — Common Stock Payments: -4741000.00
ORMP cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -4009000.00
ORMP income_statement (annual, 2025-12-31) — Cost Of Revenue: 1987000.00
ORMP income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 0.00
ORMP balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 2472000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 2472000.00
ORMP balance_sheet (annual, 2025-12-31) — Current Assets: 133271000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Current Assets: 133271000.00
ORMP balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 285000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 285000.00
ORMP balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 285000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 285000.00
ORMP balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 1353000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 1353000.00
ORMP balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 1353000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 1353000.00
ORMP balance_sheet (annual, 2025-12-31) — Current Liabilities: 19086000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 19086000.00
ORMP cash_flow (annual, 2025-12-31) — Deferred Income Tax: 7911000.00
ORMP cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -10000.00
ORMP cash_flow (annual, 2025-12-31) — Deferred Tax: 7911000.00
ORMP cash_flow (quarterly, 2025-12-31) — Deferred Tax: -10000.00
ORMP balance_sheet (annual, 2025-12-31) — Defined Pension Benefit: 44000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Defined Pension Benefit: 44000.00
ORMP cash_flow (annual, 2025-12-31) — Depreciation: 121000.00
ORMP cash_flow (quarterly, 2025-12-31) — Depreciation: 30000.00
ORMP cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 121000.00
ORMP cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 30000.00
ORMP cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 121000.00
ORMP cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 30000.00
ORMP income_statement (annual, 2025-12-31) — Diluted Average Shares: 42418644.00
ORMP income_statement (annual, 2025-12-31) — Diluted EPS: 1.50
ORMP income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 64050000.00
ORMP income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 10009000.00
ORMP balance_sheet (annual, 2025-12-31) — Dividends Payable: 10595000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Dividends Payable: 10595000.00
ORMP balance_sheet (annual, 2025-12-31) — Dueto Related Parties Current: 652000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Dueto Related Parties Current: 652000.00
ORMP income_statement (annual, 2025-12-31) — EBIT: 75324000.00
ORMP income_statement (quarterly, 2025-12-31) — EBIT: 9797000.00
ORMP income_statement (annual, 2025-12-31) — EBITDA: 75445000.00
ORMP income_statement (quarterly, 2025-12-31) — EBITDA: 9827000.00
ORMP cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -30000.00
ORMP cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -73000.00
ORMP balance_sheet (annual, 2025-12-31) — Employee Benefits: 39000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 39000.00
ORMP cash_flow (annual, 2025-12-31) — End Cash Position: 45947000.00
ORMP cash_flow (quarterly, 2025-12-31) — End Cash Position: 45947000.00
ORMP cash_flow (annual, 2025-12-31) — Financing Cash Flow: -4741000.00
ORMP cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -4009000.00
ORMP cash_flow (annual, 2025-12-31) — Free Cash Flow: -11078000.00
ORMP cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -264000.00
ORMP income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 87687000.00
ORMP income_statement (annual, 2025-12-31) — General And Administrative Expense: 8720000.00
ORMP income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 3684000.00
ORMP balance_sheet (annual, 2025-12-31) — Gross PPE: 1336000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Gross PPE: 1336000.00
ORMP income_statement (annual, 2025-12-31) — Gross Profit: 13000.00
ORMP income_statement (quarterly, 2025-12-31) — Gross Profit: 0.00
ORMP balance_sheet (annual, 2025-12-31) — Income Tax Payable: 3286000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 3286000.00
ORMP income_statement (annual, 2025-12-31) — Interest Expense: 0.00
ORMP income_statement (quarterly, 2025-12-31) — Interest Expense: 0.00
ORMP income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 0.00
ORMP income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 0.00
ORMP income_statement (annual, 2025-12-31) — Interest Income: 2373000.00
ORMP income_statement (annual, 2025-12-31) — Interest Income Non Operating: 2373000.00
ORMP cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 0.00
ORMP cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 0.00
ORMP balance_sheet (annual, 2025-12-31) — Invested Capital: 199744000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Invested Capital: 199744000.00
ORMP cash_flow (annual, 2025-12-31) — Investing Cash Flow: 5443000.00
ORMP cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -1684000.00
ORMP balance_sheet (annual, 2025-12-31) — Investment Properties: 1921000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Investment Properties: 1921000.00
ORMP balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 22114000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 22114000.00
ORMP balance_sheet (annual, 2025-12-31) — Investments And Advances: 93737000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 93737000.00
ORMP balance_sheet (annual, 2025-12-31) — Investmentsin Associatesat Cost: 71623000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Investmentsin Associatesat Cost: 71623000.00
ORMP balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 540000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 540000.00
ORMP balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 540000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 540000.00
ORMP balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 71623000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 71623000.00
ORMP balance_sheet (annual, 2025-12-31) — Minority Interest: 0.00
ORMP balance_sheet (quarterly, 2025-12-31) — Minority Interest: 0.00
ORMP income_statement (annual, 2025-12-31) — Minority Interests: 34000.00
ORMP income_statement (quarterly, 2025-12-31) — Minority Interests: 0.00
ORMP cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -7250000.00
ORMP cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 0.00
ORMP cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -4741000.00
ORMP cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -4009000.00
ORMP cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 830000.00
ORMP cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 80000.00
ORMP income_statement (annual, 2025-12-31) — Net Income: 64050000.00
ORMP income_statement (quarterly, 2025-12-31) — Net Income: 10009000.00
ORMP income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 64050000.00
ORMP income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 10009000.00
ORMP income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 64016000.00
ORMP income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 10009000.00
ORMP income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 64050000.00
ORMP income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 10009000.00
ORMP income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 64050000.00
ORMP income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 10009000.00
ORMP cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 64016000.00
ORMP cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 10009000.00
ORMP income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 64016000.00
ORMP income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 10009000.00
ORMP income_statement (annual, 2025-12-31) — Net Interest Income: 1767000.00
ORMP income_statement (quarterly, 2025-12-31) — Net Interest Income: -72511000.00
ORMP cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 8375000.00
ORMP cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -1886000.00
ORMP cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 0.00
ORMP cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 0.00
ORMP income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 1767000.00
ORMP income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -72511000.00
ORMP cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 6251000.00
ORMP cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 0.00
ORMP balance_sheet (annual, 2025-12-31) — Net PPE: 1336000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Net PPE: 1336000.00
ORMP cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -1933000.00
ORMP cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: 202000.00
ORMP cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: 0.00
ORMP balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 199744000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 199744000.00
ORMP balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 11180000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 11180000.00
ORMP balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 3269000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 3269000.00
ORMP balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 7911000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 7911000.00
ORMP balance_sheet (annual, 2025-12-31) — Non Current Note Receivables: 553000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Non Current Note Receivables: 553000.00
ORMP balance_sheet (annual, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 39000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 39000.00
ORMP balance_sheet (annual, 2025-12-31) — Non Current Prepaid Assets: 2000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Non Current Prepaid Assets: 2000.00
ORMP income_statement (annual, 2025-12-31) — Normalized EBITDA: -12242000.00
ORMP income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 9827000.00
ORMP income_statement (annual, 2025-12-31) — Normalized Income: -10473007.17
ORMP income_statement (quarterly, 2025-12-31) — Normalized Income: 10009000.00
ORMP balance_sheet (annual, 2025-12-31) — Notes Receivable: 4636000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Notes Receivable: 4636000.00
ORMP cash_flow (annual, 2025-12-31) — Operating Cash Flow: -9145000.00
ORMP cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -466000.00
ORMP cash_flow (annual, 2025-12-31) — Operating Gains Losses: 818000.00
ORMP cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 76000.00
ORMP income_statement (annual, 2025-12-31) — Operating Income: -15088000.00
ORMP income_statement (quarterly, 2025-12-31) — Operating Income: -5672000.00
ORMP income_statement (annual, 2025-12-31) — Operating Revenue: 2000000.00
ORMP income_statement (quarterly, 2025-12-31) — Operating Revenue: 0.00
ORMP balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 39275006.00
ORMP balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 39275006.00
ORMP balance_sheet (annual, 2025-12-31) — Other Current Assets: 2741000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 2741000.00
ORMP income_statement (annual, 2025-12-31) — Other Gand A: 8720000.00
ORMP income_statement (quarterly, 2025-12-31) — Other Gand A: 3684000.00
ORMP income_statement (annual, 2025-12-31) — Other Income Expense: 88645000.00
ORMP income_statement (quarterly, 2025-12-31) — Other Income Expense: 87980000.00
ORMP income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 958000.00
ORMP income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 293000.00
ORMP balance_sheet (annual, 2025-12-31) — Other Properties: 1336000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Other Properties: 1336000.00
ORMP balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 79947000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 79947000.00
ORMP balance_sheet (annual, 2025-12-31) — Payables: 14976000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Payables: 14976000.00
ORMP balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 17448000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 17448000.00
ORMP cash_flow (annual, 2025-12-31) — Pension And Employee Benefit Expense: -12000.00
ORMP cash_flow (quarterly, 2025-12-31) — Pension And Employee Benefit Expense: -4000.00
ORMP income_statement (annual, 2025-12-31) — Pretax Income: 75324000.00
ORMP income_statement (quarterly, 2025-12-31) — Pretax Income: 9797000.00
ORMP cash_flow (annual, 2025-12-31) — Purchase Of Business: -7250000.00
ORMP cash_flow (quarterly, 2025-12-31) — Purchase Of Business: 0.00
ORMP cash_flow (annual, 2025-12-31) — Purchase Of Investment: -88506000.00
ORMP cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -22689000.00
ORMP cash_flow (annual, 2025-12-31) — Purchase Of PPE: -1933000.00
ORMP cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: 202000.00
ORMP balance_sheet (annual, 2025-12-31) — Receivables: 4636000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Receivables: 4636000.00
ORMP income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 1987000.00
ORMP income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 0.00
ORMP income_statement (annual, 2025-12-31) — Reconciled Depreciation: 121000.00
ORMP income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 30000.00
ORMP cash_flow (annual, 2025-12-31) — Repayment Of Debt: 0.00
ORMP cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: 0.00
ORMP cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -4741000.00
ORMP cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -4009000.00
ORMP income_statement (annual, 2025-12-31) — Research And Development: 6381000.00
ORMP income_statement (quarterly, 2025-12-31) — Research And Development: 1988000.00
ORMP balance_sheet (annual, 2025-12-31) — Retained Earnings: -123436000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -123436000.00
ORMP cash_flow (annual, 2025-12-31) — Sale Of Investment: 96881000.00
ORMP cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 20803000.00
ORMP income_statement (annual, 2025-12-31) — Selling General And Administration: 8720000.00
ORMP income_statement (quarterly, 2025-12-31) — Selling General And Administration: 3684000.00
ORMP balance_sheet (annual, 2025-12-31) — Share Issued: 39275006.00
ORMP balance_sheet (quarterly, 2025-12-31) — Share Issued: 39275006.00
ORMP cash_flow (annual, 2025-12-31) — Short Term Debt Payments: 0.00
ORMP cash_flow (annual, 2025-12-31) — Stock Based Compensation: 5992000.00
ORMP cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 2284000.00
ORMP balance_sheet (annual, 2025-12-31) — Stockholders Equity: 199744000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 199744000.00
ORMP balance_sheet (annual, 2025-12-31) — Tangible Book Value: 199744000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 199744000.00
ORMP income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 13163992.83
ORMP income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
ORMP income_statement (annual, 2025-12-31) — Tax Provision: 11308000.00
ORMP income_statement (quarterly, 2025-12-31) — Tax Provision: -212000.00
ORMP income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.15
ORMP income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
ORMP balance_sheet (annual, 2025-12-31) — Total Assets: 230864000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Total Assets: 230864000.00
ORMP balance_sheet (annual, 2025-12-31) — Total Capitalization: 199744000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 199744000.00
ORMP balance_sheet (annual, 2025-12-31) — Total Debt: 825000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Total Debt: 825000.00
ORMP balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 199744000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 199744000.00
ORMP income_statement (annual, 2025-12-31) — Total Expenses: 17088000.00
ORMP income_statement (quarterly, 2025-12-31) — Total Expenses: 5672000.00
ORMP balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 31120000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 31120000.00
ORMP balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 97593000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 97593000.00
ORMP balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 12034000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 12034000.00
ORMP income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -15088000.00
ORMP income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -5672000.00
ORMP income_statement (annual, 2025-12-31) — Total Other Finance Cost: 606000.00
ORMP income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: 74884000.00
ORMP balance_sheet (annual, 2025-12-31) — Total Tax Payable: 3286000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 3286000.00
ORMP income_statement (annual, 2025-12-31) — Total Unusual Items: 87687000.00
ORMP income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 87687000.00
ORMP balance_sheet (annual, 2025-12-31) — Tradeand Other Payables Non Current: 275000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Tradeand Other Payables Non Current: 275000.00
ORMP balance_sheet (annual, 2025-12-31) — Trading Securities: 8371000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Trading Securities: 8371000.00
ORMP cash_flow (annual, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -86096000.00
ORMP cash_flow (quarterly, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -13504000.00
ORMP balance_sheet (annual, 2025-12-31) — Working Capital: 114185000.00
ORMP balance_sheet (quarterly, 2025-12-31) — Working Capital: 114185000.00
ORMP income_statement (quarterly, 2026-03-31) — +Operating Expense: 3659000.00
ORMP income_statement (quarterly, 2026-03-31) — +Total Revenue: 0.00
ORMP balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 481000.00
ORMP balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 322906000.00
ORMP balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 72269000.00
ORMP income_statement (quarterly, 2026-03-31) — Basic Average Shares: 40773866.00
ORMP income_statement (quarterly, 2026-03-31) — Basic EPS: 0.94
ORMP cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 45947000.00
ORMP cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -5000.00
ORMP balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 761000.00
ORMP balance_sheet (quarterly, 2026-03-31) — Capital Stock: 491000.00
ORMP balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 13202000.00
ORMP balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 65840000.00
ORMP cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -10364000.00
ORMP cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -10364000.00
ORMP cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -19488000.00
ORMP cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -2915000.00
ORMP cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 149000.00
ORMP cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: 0.00
ORMP cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -2593000.00